company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6641000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6641000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4841000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,830000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10557000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5565000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,28434000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,28434000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26559000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-740000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61287000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46359000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-42227000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-42227000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-45000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5566000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8272000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1976000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q3,2009-07-01,2009-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,253000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4711000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4711000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4861000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,954000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6470000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2470000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19466000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19466000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22621000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-18257000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106893000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,102250000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-45521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-45521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2515000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1018000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1448000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1448000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24607000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2765000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2009.0,Q4,2009-10-01,2009-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1758000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1151000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1151000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5410000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1198000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8310000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12819000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,3250000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,3250000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14108000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15589000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-62956000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22055000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-70598000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-70598000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-43000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9183000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9140000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9140000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-58208000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1822000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q1,2010-01-01,2010-03-31,2011-04-29 13:08:51+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,254000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-477000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-477000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6577000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1303000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9063000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5755000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,22221000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,22221000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15240000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26516000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28627000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13129000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13129000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3983000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6217000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2276000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2276000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6816000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2702000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,2010-04-01,2010-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,929000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4371000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4371000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8585000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1080000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9877000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18670000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3499000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3499000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6241000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-593000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74210000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,84013000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-315000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3133000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,415000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3233000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3233000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2703000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,637000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,2011-01-01,2011-03-31,2012-04-30 17:13:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,616000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5077000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5077000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8531000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,973000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14358000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5219000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13566000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13566000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1910000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-655000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58355000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61626000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,706000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,706000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-156000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8445000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-387000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7902000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7902000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22174000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3046000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,2011-04-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1682000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17653000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17653000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,9350000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1002000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17789000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1627000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8861000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8861000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-56388000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-655000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-82733000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81455000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-58321000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-58321000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2287000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11858000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1813000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7758000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7758000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-41702000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,336000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,2011-07-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1088000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26735000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26735000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,8580000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,981000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14014000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2647000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-513000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-513000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8680000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-81000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-131000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,54897000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-34914000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-34914000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10156000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,306000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,10445000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10445000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24982000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3196000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1009000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23972000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23972000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10598000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,852000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16697000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11346000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7171000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7171000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6179000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36562000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74037000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30038000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30038000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-250000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13679000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13447000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13447000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36314000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,293000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,2012-01-01,2012-03-31,2013-04-29 15:07:36+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1739000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32006000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32006000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11173000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,886000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11642000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6885000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1420000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1420000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-9484000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-175909000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33010000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-152383000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-152383000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,250000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,393000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,249051000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,66000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,249760000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,248974000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,95171000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3074000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,2012-04-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3175000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5357000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5357000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11667000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1337000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9808000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3241000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14214000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14214000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15013000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-64346000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,58412000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-20947000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-20947000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,10306000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3573000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,230000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,2012-07-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,677000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39810000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39810000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11348000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1456000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22053000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-27076000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32029000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32029000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11826000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-9875000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68770000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,82531000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7940000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7940000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-10661000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,24483000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13822000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13822000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26147000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1998000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 12:15:41+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,646000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21533000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21533000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12868000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1373000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14157000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13682000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6817000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6817000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-10412000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-485000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-49411000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72568000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12260000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12260000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-143000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15765000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15622000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15622000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,21065000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1035000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,2013-04-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10742000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53020000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53020000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13312000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1320000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18555000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10341000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9492000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9492000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13202000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-61011000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,77526000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3313000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3313000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1876000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14175000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12299000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12299000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6120000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,205000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1777000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61990000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61990000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-1514000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1750000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,29148000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23609000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8997000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8997000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29753000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,485000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-215850000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56018000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-117385000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-306485000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-306485000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-892000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,726202000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72579000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-92961000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,704928000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,704928000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2230000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,387216000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,-1079000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1732000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7445000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7445000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14225000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2007000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-39691000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7457000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8557000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8557000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25170000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-316018000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,67500000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,87810000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1600000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-187478000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-187478000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,16000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9533000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-678000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8871000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8871000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,452000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-186712000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-96000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9287000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-69797000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-69797000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5966000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,28688000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9726000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1510000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23907000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23907000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27767000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58098000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,600837000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-52288000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,462684000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,462684000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-20000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42269000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-727000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41522000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41522000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2818000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,477481000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4565000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12608000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-67501000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-67501000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10817000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,417000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23349000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-104893000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-137811000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-137811000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43832000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-538392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-288431000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,124137000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4353000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-750871000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-750871000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1284000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,916283000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1262000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,914791000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,914791000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1025000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,25084000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 09:01:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1358000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-81989000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-81989000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11446000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,14604000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28765000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,14183000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12991000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12991000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35456000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-440832000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30063000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1027000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-445198000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-445198000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2351000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2351000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,634000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-459906000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,5133000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,2015-04-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12456000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90926000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90926000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12038000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7838000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22730000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45470000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2850000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2850000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44556000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-113610000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,107586000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12500000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-63080000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-63080000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,1000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6088000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2324000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3765000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3765000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2153000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-64318000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-154000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1563000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,68617000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,68617000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12886000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7811000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-141449000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13712000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-65847000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65847000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-103809000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30311000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,410000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,162927000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-359256000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,79551000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,79551000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-528000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11530000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1484000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9518000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9518000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2528000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,20694000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4328000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,707000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-83051000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-83051000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18726000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7646000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24177000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-138952000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-171454000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-171454000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-45204000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58914000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,181267000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-150000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,76999000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,76999000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-40788000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-37264000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-37264000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5132000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-126587000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:42:07+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,73215000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-419014000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-419014000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28657000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7652000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,633866000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-296966000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45805000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45805000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25506000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1467000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,102513000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,75540000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,75540000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-3000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19493000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12036000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7454000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7454000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1673000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35516000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,2016-04-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,20754000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37425000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37425000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29422000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7659000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,30398000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-40422000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10368000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10368000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26096000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-311479000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19021000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8383000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-326937000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-326937000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,739422000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2417000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,737005000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,737005000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1680000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,401380000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,43000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,2016-07-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1194000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90720000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90720000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20107000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8273000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31281000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,30849000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-210000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-210000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-51574000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1322000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-329356000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,64768000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7835000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-309649000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-309649000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-588000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24729000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4228000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19913000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19913000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9073000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-299019000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4079000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q4,2016-10-01,2016-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,694000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16290000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16290000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19412000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8415000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,26661000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-118641000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-80443000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-80443000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-69090000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54388000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,149916000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1391000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25047000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25047000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13086000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-19829000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6743000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6743000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2043000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-60096000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 06:06:22+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6376000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36833000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36833000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19085000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,8513000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,39798000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11783000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18780000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18780000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-47757000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-76598000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,84701000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-169000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-39823000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-39823000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-28000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27573000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8689000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18856000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18856000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8817000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6630000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4519000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,2017-04-01,2017-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9965000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12527000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12527000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20700000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9026000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,45972000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24879000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,38292000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,38292000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42482000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-478808000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,91061000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-430229000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-430229000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,2000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,481713000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5460000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5239000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,481936000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,481936000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13464000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,76535000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-232000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,5403000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28664000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9423000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-88227000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,116146000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14614000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14614000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39890000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45653000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,125000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,100282000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-193000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,139546000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,139546000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14740000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1644000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13096000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13096000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-627000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,166629000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4257000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2151000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44149000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44149000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23633000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9362000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42886000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-74241000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42509000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42509000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30164000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-145933000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104462000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-99000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-71734000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-71734000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13134000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-22899000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9765000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9765000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-40000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-124048000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1528000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,2018-01-01,2018-03-31,2019-04-29 06:08:45+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11731000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16792000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16792000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20977000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,7897000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8407000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-54346000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33857000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33857000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22518000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-199525000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,20000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,207507000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-742000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4722000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4722000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,31792000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-48823000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-17031000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-17031000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-403000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-46569000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4303000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,2018-04-01,2018-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3127000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12620000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12620000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26345000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9609000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28512000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4646000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,47200000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,47200000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49859000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-93740000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,545094000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,831000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,402326000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,402326000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10717000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5566000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5151000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5151000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,96000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,454773000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1690000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,2018-07-01,2018-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,933000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3650000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3650000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24716000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4676000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-1099000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24731000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,49374000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,49374000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42079000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-195555000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,30000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,136671000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-70963000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-70963000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-374953000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11845000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3254000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-366362000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-366362000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-251000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-388202000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4102000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,885000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56473000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56473000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,22427000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3518000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42323000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-66663000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-54868000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-54868000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28756000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1706000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-239843000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,219894000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-68000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-50479000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-50479000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-674000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5798000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-30105000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24981000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24981000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,715000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-129613000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1483000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-01 13:54:26+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,906000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37435000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37435000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26344000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,3842000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,22463000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-39552000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24338000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24338000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32631000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4064000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-146477000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,203583000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-740000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19671000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19671000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-673000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13215000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-64302000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-51760000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-51760000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-365000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-56792000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2812000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3027000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,55036000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,55036000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30739000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,138000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,42743000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-58531000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,70125000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,70125000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-32854000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2553000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-142177000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,15000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,212201000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-939000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,48678000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,48678000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-678000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2755000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4052000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1975000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1975000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1185000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,115643000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1482000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,2019-07-01,2019-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2155000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15024000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15024000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,25790000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,4462000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25968000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-13901000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,57343000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,57343000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50785000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-10057000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-103526000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,10000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,104533000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,939000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-48896000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-48896000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3062000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9843000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2739000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4042000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4042000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1737000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14226000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2775000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q4,2019-10-01,2019-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3638000.0
